Prediction of Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics
Condition: Esophageal and Gastric Varices Intervention: Diagnostic Test: tongue diagnosis Sponsors: Qilu Hospital of Shandong University; Jinan Central Hospital; Qianfoshan Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Prediction of Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics
Condition: Esophageal Varices Intervention: Diagnostic Test: tongue diagnosis Sponsors: Qilu Hospital of Shandong University; Jinan Central Hospital; Qianfoshan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Risk Factors for Advanced Fibrosis Among FLD Patients
Conditions: NAFLD; Liver Cirrhosis; Diabetes Mellitus, Type 2 Intervention: Other: Follow-up Sponsors: Helsinki University Central Hospital; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Real-world Elecsys ® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: Elecsys® GAAD Sponsors: Manchester University NHS Foundation Trust; University of Manchester; Roche Pharma AG; Unity Insights; Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
